查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1447964

北美毒理學實驗室市場-北美行業分析,規模,佔有率,成長,趨勢,預測(2023-2030)-依藥物類別,產品類型,樣本,國家,公司

North America Toxicology Laboratories Market - North America Toxicology Laboratories Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - (By Drug Class, By Product Type, By Sample, By Geographic Coverage and By Company)
出版日期: | 出版商: Fairfield Market Research | 英文 100 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

北美毒理學實驗室市場規模預計將從 2023 年的 2.552 億美元激增至 2030 年底的 5.112 億美元，預測期內複合年增長率為 10.4%。

推動市場擴張的主要趨勢包括快速篩選技術的重要性日益增加。氣相層析質譜 (GC-MS) 等技術的進步增加了毒理學實驗室對高效篩選方法的需求，從而增加了周轉時間和靈敏度。

本報告中確定的另一個重要趨勢是毒理學實驗室中資訊學和數據解決方案的整合。敏感的測試結果安全地儲存在質譜資料庫中，凸顯了資料完整性和保密性在該行業中的重要性。

該報告考察了北美毒理學實驗室市場，並提供了市場概述，包括依藥物類別、產品類型、樣本、國家、公司以及進入市場的公司的競爭趨勢劃分的趨勢。

目錄

第一章執行摘要

第二章市場概況

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • COVID-19 影響分析
  • 經濟概況
  • 杵分析

第三章 2018-2030年北美毒理學實驗室市場展望

  • 北美毒理學實驗室市場展望，依藥物類別、價值（百萬美元），2018-2030 年
  • 北美毒理學實驗室市場展望，依產品類型和價值（百萬美元），2018-2030 年
  • 北美毒理學實驗室市場展望，依樣本，價值（百萬美元），2018-2030
  • 北美毒理學實驗室市場展望，依國家/地區劃分，價值（百萬美元），2018-2030 年

第四章 競爭狀況

  • 2022 年企業市佔率分析
  • 主要公司的市場集中度
  • 比賽儀表板
  • 公司簡介
    • Thermo Fisher Scientific
    • Bio-Rad Laboratories, Inc.
    • NEOGEN Corporation
    • Redwood Toxicology Laboratory, Inc.
    • Vala Sciences, Inc.
    • Enzo Life Sciences, Inc.
    • Alere, Inc.
    • Agilent Technologies, Inc.
    • Immunalysis Corporation
    • Danaher Corporation
    • Principle Diagnostics Laboratory
    • Principle Laboratory
    • Principle Diagnostics Laboratory
    • Clinical Reference Laboratory, Inc.
    • Medical Toxicology Laboratory, LLC
    • NMS Labs
    • BATTS Laboratories
    • Total Toxicology
    • Life Brite Labs.
    • Product Safety Labs
    • Lexar Labs

第5章附錄

簡介目錄

The North America toxicology laboratories market, unveiling promising forecasts and insightful trends driving the industry's evolution. With an impeccable Compound Annual Growth Rate (CAGR) of 10.4% projected during the forecast period, the market is expected to surge from US$255.2 million in 2023 to an estimated US$511.2 million by the end of 2030.

Rapid Screening Technologies: A Key Driver of Growth

The report highlights the increasing significance of rapid screening technologies as a primary trend propelling market expansion. With advancements in technologies such as Gas Chromatography-Mass Spectrometry (GC-MS), toxicology laboratories are witnessing a surge in demand for efficient screening methods, enhancing turnaround times and sensitivity.

Integration of Informatics and Data Solutions

Another pivotal trend identified in the report is the integration of informatics and data solutions within toxicology laboratories. Confidential test results are securely stored in mass spectral databases, emphasizing the importance of data integrity and confidentiality in the industry.

Key Segment Insights

  • Drug Class Dominance: Amphetamines emerge as the leading segment, capturing 17.9% of the market share and projected to grow at a robust CAGR of 11.0% during the forecast period.
  • Product Type Leadership: Reagent and kits claim the majority share of 61.6%, expected to grow at a steady CAGR of 9.7% over the forecast period.

Regulatory Frameworks Fueling Market Growth

The report underscores the role of robust regulatory frameworks in driving market growth across industries such as pharmaceuticals, cosmetics, food, and chemicals. Stricter regulations in the US and Canada mandate rigorous testing, creating a conducive environment for market expansion.

Challenges and Opportunities

While traditional toxicology laboratories face challenges from the introduction of point-of-care testing devices, increasing government spending on toxicity testing presents lucrative opportunities for market players. Collaborations between regulatory bodies and industry stakeholders further stimulate innovation and growth.

Competitive Analysis

Prominent organizations are spearheading the sector with innovative solutions and strategic alliances. Competitive intelligence and strategic decision-making remain crucial for companies navigating the dynamic landscape of the toxicology laboratories market.

Global North America Toxicology Laboratories Market:

  • Thermo Fisher Scientific, Inc.
  • Bio Rad Laboratories Inc.
  • Neogen Corporation
  • Danaher Corporation
  • Agilent
  • Redwood Toxicology Laboratory
  • Abbott (Alere, Inc.)

Global North America Toxicology Laboratories Market Is Segmented as Below:

Drug Class:

  • Alcohol
  • Amphetamines
  • Barbiturates
  • Benzodiazepines
  • Illicit Drugs
  • Opiates/Opioids
  • Tricyclic's Antidepressants
  • Z Drugs
  • Misc

Product Type:

  • Reagent Kits
    • ELISA
    • PCR
    • Enzyme Multiplied Immunoassay Technique (EMIT)
    • Radio Immuno-sorbent Assay (RIA)
  • Instruments
    • Immunochemistry Analyzers
    • PCR Machine
    • Gas Chromatography/Mass Spectrometry (GS/MS)
    • High Performance Liquid Chromatography (HPLC)

Sample:

  • Urine
  • Blood
  • Hair
  • Oral Fluid

End User:

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Forensic Laboratories
  • Rehabilitation Centers

By Geographic Coverage:

  • North America
    • U.S.
    • Canada

Table of Contents

1. Executive Summary

  • 1.1. North America Toxicology Laboratories Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2022
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. Covid-19 Impact Analysis
    • 2.5.1. Overview
    • 2.5.2. Impact By Region
  • 2.6. Economic Overview
    • 2.6.1. World Economic Projections
  • 2.7. PESTLE Analysis

3. North America Toxicology Laboratories Market Outlook, 2018 - 2030

  • 3.1. North America Toxicology Laboratories Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2030
    • 3.1.1. Key Highlights
      • 3.1.1.1. Alcohol
      • 3.1.1.2. Amphetamines
      • 3.1.1.3. Barbiturates
      • 3.1.1.4. Benzodiazepines
      • 3.1.1.5. Illicit Drugs
      • 3.1.1.6. Opiates/Opioids
      • 3.1.1.7. Tricyclic's Antidepressants
      • 3.1.1.8. Z Drugs
      • 3.1.1.9. Others
  • 3.2. North America Toxicology Laboratories Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2030
    • 3.2.1. Key Highlights
      • 3.2.1.1. Reagent Kits
        • 3.2.1.1.1. ELISA
        • 3.2.1.1.2. PCR
        • 3.2.1.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
        • 3.2.1.1.4. Radio Immuno-sorbent Assay (RIA)
      • 3.2.1.2. Instruments
        • 3.2.1.2.1. Immunochemistry Analyzers
        • 3.2.1.2.2. PCR Machine
        • 3.2.1.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
        • 3.2.1.2.4. High Performance Liquid Chromatography (HPLC)
  • 3.3. North America Toxicology Laboratories Market Outlook, by Sample, Value (US$ Mn), 2018 - 2030
    • 3.3.1. Key Highlights
      • 3.3.1.1. Urine
      • 3.3.1.2. Blood
      • 3.3.1.3. Hair
      • 3.3.1.4. Oral Fluid
    • 3.3.2. Market Attractiveness Analysis
  • 3.4. North America Toxicology Laboratories Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 3.4.1. Key Highlights
      • 3.4.1.1. U.S. Toxicology Laboratories Market by Drug Class, Value (US$ Mn), 2018 - 2030
      • 3.4.1.2. U.S. Toxicology Laboratories Market, by Product Type, Value (US$ Mn), 2018 - 2030
      • 3.4.1.3. U.S. Toxicology Laboratories Market, by Sample, Value (US$ Mn), 2018 - 2030
      • 3.4.1.4. Canada Toxicology Laboratories Market by Drug Class, Value (US$ Mn), 2018 - 2030
      • 3.4.1.5. Canada Toxicology Laboratories Market, by Product Type, Value (US$ Mn), 2018 - 2030
      • 3.4.1.6. Canada Toxicology Laboratories Market, by Sample, Value (US$ Mn), 2018 - 2030
    • 3.4.2. Market Attractiveness Analysis

4. Competitive Landscape

  • 4.1. Company Market Share Analysis, 2022
  • 4.2. Market Concentration by Top Players
  • 4.3. Competitive Dashboard
  • 4.4. Company Profiles
    • 4.4.1. Thermo Fisher Scientific
      • 4.4.1.1. Company Overview
      • 4.4.1.2. Product Portfolio
      • 4.4.1.3. Financial Overview
      • 4.4.1.4. Business Strategies and Development
    • 4.4.2. Bio-Rad Laboratories, Inc.
      • 4.4.2.1. Company Overview
      • 4.4.2.2. Product Portfolio
      • 4.4.2.3. Financial Overview
      • 4.4.2.4. Business Strategies and Development
    • 4.4.3. NEOGEN Corporation
      • 4.4.3.1. Company Overview
      • 4.4.3.2. Product Portfolio
      • 4.4.3.3. Financial Overview
      • 4.4.3.4. Business Strategies and Development
    • 4.4.4. Redwood Toxicology Laboratory, Inc.
      • 4.4.4.1. Company Overview
      • 4.4.4.2. Product Portfolio
      • 4.4.4.3. Financial Overview
      • 4.4.4.4. Business Strategies and Development
    • 4.4.5. Vala Sciences, Inc.
      • 4.4.5.1. Company Overview
      • 4.4.5.2. Product Portfolio
      • 4.4.5.3. Financial Overview
      • 4.4.5.4. Business Strategies and Development
    • 4.4.6. Enzo Life Sciences, Inc.
      • 4.4.6.1. Company Overview
      • 4.4.6.2. Product Portfolio
      • 4.4.6.3. Financial Overview
      • 4.4.6.4. Business Strategies and Development
    • 4.4.7. Alere, Inc.
      • 4.4.7.1. Company Overview
      • 4.4.7.2. Product Portfolio
      • 4.4.7.3. Financial Overview
      • 4.4.7.4. Business Strategies and Development
    • 4.4.8. Agilent Technologies, Inc.
      • 4.4.8.1. Company Overview
      • 4.4.8.2. Product Portfolio
      • 4.4.8.3. Financial Overview
      • 4.4.8.4. Business Strategies and Development
    • 4.4.9. Immunalysis Corporation
      • 4.4.9.1. Company Overview
      • 4.4.9.2. Product Portfolio
      • 4.4.9.3. Financial Overview
      • 4.4.9.4. Business Strategies and Development
    • 4.4.10. Danaher Corporation
      • 4.4.10.1. Company Overview
      • 4.4.10.2. Product Portfolio
      • 4.4.10.3. Financial Overview
      • 4.4.10.4. Business Strategies and Development
    • 4.4.11. Principle Diagnostics Laboratory
      • 4.4.11.1. Company Overview
      • 4.4.11.2. Product Portfolio
      • 4.4.11.3. Financial Overview
      • 4.4.11.4. Business Strategies and Development
    • 4.4.12. Principle Laboratory
      • 4.4.12.1. Company Overview
      • 4.4.12.2. Product Portfolio
      • 4.4.12.3. Financial Overview
      • 4.4.12.4. Business Strategies and Development
    • 4.4.13. Principle Diagnostics Laboratory
      • 4.4.13.1. Company Overview
      • 4.4.13.2. Product Portfolio
      • 4.4.13.3. Financial Overview
      • 4.4.13.4. Business Strategies and Development
    • 4.4.14. Clinical Reference Laboratory, Inc.
      • 4.4.14.1. Company Overview
      • 4.4.14.2. Product Portfolio
      • 4.4.14.3. Financial Overview
      • 4.4.14.4. Business Strategies and Development
    • 4.4.15. Medical Toxicology Laboratory, LLC
      • 4.4.15.1. Company Overview
      • 4.4.15.2. Product Portfolio
      • 4.4.15.3. Financial Overview
      • 4.4.15.4. Business Strategies and Development
    • 4.4.16. NMS Labs
      • 4.4.16.1. Company Overview
      • 4.4.16.2. Product Portfolio
      • 4.4.16.3. Financial Overview
      • 4.4.16.4. Business Strategies and Development
    • 4.4.17. BATTS Laboratories
      • 4.4.17.1. Company Overview
      • 4.4.17.2. Product Portfolio
      • 4.4.17.3. Financial Overview
      • 4.4.17.4. Business Strategies and Development
    • 4.4.18. Total Toxicology
      • 4.4.18.1. Company Overview
      • 4.4.18.2. Product Portfolio
      • 4.4.18.3. Financial Overview
      • 4.4.18.4. Business Strategies and Development
    • 4.4.19. Life Brite Labs.
      • 4.4.19.1. Company Overview
      • 4.4.19.2. Product Portfolio
      • 4.4.19.3. Financial Overview
      • 4.4.19.4. Business Strategies and Development
    • 4.4.20. Product Safety Labs
      • 4.4.20.1. Company Overview
      • 4.4.20.2. Product Portfolio
      • 4.4.20.3. Financial Overview
      • 4.4.20.4. Business Strategies and Development
    • 4.4.21. Lexar Labs
      • 4.4.21.1. Company Overview
      • 4.4.21.2. Product Portfolio
      • 4.4.21.3. Financial Overview
      • 4.4.21.4. Business Strategies and Development

5. Appendix

  • 5.1. Research Methodology
  • 5.2. Report Assumptions
  • 5.3. Acronyms and Abbreviations